HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

László Urbán Selected Research

Tyrosine Kinase Inhibitors

8/2020Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


László Urbán Research Topics

Disease

2Adenocarcinoma of Lung
01/2021 - 08/2020
2Neoplasms (Cancer)
01/2021 - 08/2020
1Lung Neoplasms (Lung Cancer)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2020
1Inflammatory Breast Neoplasms
09/2011
1Hypertension (High Blood Pressure)
01/2007

Drug/Important Bio-Agent (IBA)

1AfatinibIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
08/2020
1Anaplastic Lymphoma KinaseIBA
08/2020
1CrizotinibIBA
08/2020
1Docetaxel (Taxotere)FDA Link
09/2011

Therapy/Procedure

2Therapeutics
01/2021 - 01/2007
1Precision Medicine
08/2020
1Drug Therapy (Chemotherapy)
09/2011